Cooley Named International Healthcare & Life Sciences Firm of the Year by China Law & Practice

Firm also won Equity Securities Deal of the Year award

Beijing – September 16, 2022 – Cooley was named International Firm of the Year in the category of healthcare & life sciences for the second consecutive year as part of China Law & Practice’s annual awards. Additionally, the firm won the Equity Securities Deal of the Year award based on its representation of the underwriters in LianBio’s $325 million initial public offering.

The awards ceremony, which took place in Beijing on September 8, identifies and honors the biggest and most important commercial legal matters involving lawyers and parties in China.

The China Law & Practice distinctions complement Cooley’s continued growth in Asia. The firm regularly advises Asia-based clients on unique business opportunities and legal challenges across the region, with strategically located offices in Shanghai, Beijing, Hong Kong and Singapore to handle the most complicated cross-border matters.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,500 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of 3,300.